Utilization and outcomes of temporary mechanical circulatory support for graft dysfunction after heart transplantation

Kevin Phan, Jessica G.Y. Luc, Joshua Xu, Simon Maltais, John M. Stulak, Tristan D. Yan, Vakhtang Tchantchaleishvili

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

Graft dysfunction is the main cause of early mortality after heart transplantation. In cases of severe graft dysfunction, temporary mechanical circulatory support (TMCS) may be necessary. The aim of this systematic review was to examine the utilization and outcomes of TMCS in patients with graft dysfunction after heart transplantation. Electronic search was performed to identify all studies in the English literature assessing the use of TMCS for graft dysfunction. All identified articles were systematically assessed for inclusion and exclusion criteria. Of the 5,462 studies identified, 41 studies were included. Among the 11,555 patients undergoing heart transplantation, 695 (6.0%) required TMCS with patients most often supported using venoarterial extracorporeal membrane oxygenation (79.4%) followed by right ventricular assist devices (11.1%), biventricular assist devices (BiVADs) (7.5%), and left ventricular assist devices (LVADs) (2.0%). Patients supported by LVADs were more likely to be supported longer (p = 0.003), have a higher death by cardiac event (p = 0.013) and retransplantation rate (p = 0.015). In contrast, patients supported with BiVAD and LVAD were more likely to be weaned off support (p = 0.020). Overall, no significant difference was found in pooled 30 day survival (p = 0.31), survival to discharge (p = 0.19), and overall survival (p = 0.51) between the subgroups. Temporary mechanical circulatory support is an effective modality to support patients with graft dysfunction after heart transplantation. Further studies are needed to establish the optimal threshold and strategy for TMCS and to augment cardiac recovery and long-term survival.

Original languageEnglish (US)
Pages (from-to)695-703
Number of pages9
JournalASAIO Journal
Volume63
Issue number6
DOIs
StatePublished - Jan 1 2017

Fingerprint

Transplantation (surgical)
Heart Transplantation
Grafts
Left ventricular assist devices
Heart-Assist Devices
Transplants
Survival
Oxygenation
Literature
Extracorporeal Membrane Oxygenation
Membranes
Recovery
Equipment and Supplies
Mortality

Keywords

  • Graft failure
  • Heart transplantation
  • Temporary mechanical circulatory support

ASJC Scopus subject areas

  • Biophysics
  • Bioengineering
  • Biomaterials
  • Biomedical Engineering

Cite this

Utilization and outcomes of temporary mechanical circulatory support for graft dysfunction after heart transplantation. / Phan, Kevin; Luc, Jessica G.Y.; Xu, Joshua; Maltais, Simon; Stulak, John M.; Yan, Tristan D.; Tchantchaleishvili, Vakhtang.

In: ASAIO Journal, Vol. 63, No. 6, 01.01.2017, p. 695-703.

Research output: Contribution to journalReview article

Phan, Kevin ; Luc, Jessica G.Y. ; Xu, Joshua ; Maltais, Simon ; Stulak, John M. ; Yan, Tristan D. ; Tchantchaleishvili, Vakhtang. / Utilization and outcomes of temporary mechanical circulatory support for graft dysfunction after heart transplantation. In: ASAIO Journal. 2017 ; Vol. 63, No. 6. pp. 695-703.
@article{a841c33e4ead417196bc358d2225c63c,
title = "Utilization and outcomes of temporary mechanical circulatory support for graft dysfunction after heart transplantation",
abstract = "Graft dysfunction is the main cause of early mortality after heart transplantation. In cases of severe graft dysfunction, temporary mechanical circulatory support (TMCS) may be necessary. The aim of this systematic review was to examine the utilization and outcomes of TMCS in patients with graft dysfunction after heart transplantation. Electronic search was performed to identify all studies in the English literature assessing the use of TMCS for graft dysfunction. All identified articles were systematically assessed for inclusion and exclusion criteria. Of the 5,462 studies identified, 41 studies were included. Among the 11,555 patients undergoing heart transplantation, 695 (6.0{\%}) required TMCS with patients most often supported using venoarterial extracorporeal membrane oxygenation (79.4{\%}) followed by right ventricular assist devices (11.1{\%}), biventricular assist devices (BiVADs) (7.5{\%}), and left ventricular assist devices (LVADs) (2.0{\%}). Patients supported by LVADs were more likely to be supported longer (p = 0.003), have a higher death by cardiac event (p = 0.013) and retransplantation rate (p = 0.015). In contrast, patients supported with BiVAD and LVAD were more likely to be weaned off support (p = 0.020). Overall, no significant difference was found in pooled 30 day survival (p = 0.31), survival to discharge (p = 0.19), and overall survival (p = 0.51) between the subgroups. Temporary mechanical circulatory support is an effective modality to support patients with graft dysfunction after heart transplantation. Further studies are needed to establish the optimal threshold and strategy for TMCS and to augment cardiac recovery and long-term survival.",
keywords = "Graft failure, Heart transplantation, Temporary mechanical circulatory support",
author = "Kevin Phan and Luc, {Jessica G.Y.} and Joshua Xu and Simon Maltais and Stulak, {John M.} and Yan, {Tristan D.} and Vakhtang Tchantchaleishvili",
year = "2017",
month = "1",
day = "1",
doi = "10.1097/MAT.0000000000000599",
language = "English (US)",
volume = "63",
pages = "695--703",
journal = "ASAIO Journal",
issn = "0162-1432",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Utilization and outcomes of temporary mechanical circulatory support for graft dysfunction after heart transplantation

AU - Phan, Kevin

AU - Luc, Jessica G.Y.

AU - Xu, Joshua

AU - Maltais, Simon

AU - Stulak, John M.

AU - Yan, Tristan D.

AU - Tchantchaleishvili, Vakhtang

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Graft dysfunction is the main cause of early mortality after heart transplantation. In cases of severe graft dysfunction, temporary mechanical circulatory support (TMCS) may be necessary. The aim of this systematic review was to examine the utilization and outcomes of TMCS in patients with graft dysfunction after heart transplantation. Electronic search was performed to identify all studies in the English literature assessing the use of TMCS for graft dysfunction. All identified articles were systematically assessed for inclusion and exclusion criteria. Of the 5,462 studies identified, 41 studies were included. Among the 11,555 patients undergoing heart transplantation, 695 (6.0%) required TMCS with patients most often supported using venoarterial extracorporeal membrane oxygenation (79.4%) followed by right ventricular assist devices (11.1%), biventricular assist devices (BiVADs) (7.5%), and left ventricular assist devices (LVADs) (2.0%). Patients supported by LVADs were more likely to be supported longer (p = 0.003), have a higher death by cardiac event (p = 0.013) and retransplantation rate (p = 0.015). In contrast, patients supported with BiVAD and LVAD were more likely to be weaned off support (p = 0.020). Overall, no significant difference was found in pooled 30 day survival (p = 0.31), survival to discharge (p = 0.19), and overall survival (p = 0.51) between the subgroups. Temporary mechanical circulatory support is an effective modality to support patients with graft dysfunction after heart transplantation. Further studies are needed to establish the optimal threshold and strategy for TMCS and to augment cardiac recovery and long-term survival.

AB - Graft dysfunction is the main cause of early mortality after heart transplantation. In cases of severe graft dysfunction, temporary mechanical circulatory support (TMCS) may be necessary. The aim of this systematic review was to examine the utilization and outcomes of TMCS in patients with graft dysfunction after heart transplantation. Electronic search was performed to identify all studies in the English literature assessing the use of TMCS for graft dysfunction. All identified articles were systematically assessed for inclusion and exclusion criteria. Of the 5,462 studies identified, 41 studies were included. Among the 11,555 patients undergoing heart transplantation, 695 (6.0%) required TMCS with patients most often supported using venoarterial extracorporeal membrane oxygenation (79.4%) followed by right ventricular assist devices (11.1%), biventricular assist devices (BiVADs) (7.5%), and left ventricular assist devices (LVADs) (2.0%). Patients supported by LVADs were more likely to be supported longer (p = 0.003), have a higher death by cardiac event (p = 0.013) and retransplantation rate (p = 0.015). In contrast, patients supported with BiVAD and LVAD were more likely to be weaned off support (p = 0.020). Overall, no significant difference was found in pooled 30 day survival (p = 0.31), survival to discharge (p = 0.19), and overall survival (p = 0.51) between the subgroups. Temporary mechanical circulatory support is an effective modality to support patients with graft dysfunction after heart transplantation. Further studies are needed to establish the optimal threshold and strategy for TMCS and to augment cardiac recovery and long-term survival.

KW - Graft failure

KW - Heart transplantation

KW - Temporary mechanical circulatory support

UR - http://www.scopus.com/inward/record.url?scp=85041325135&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041325135&partnerID=8YFLogxK

U2 - 10.1097/MAT.0000000000000599

DO - 10.1097/MAT.0000000000000599

M3 - Review article

VL - 63

SP - 695

EP - 703

JO - ASAIO Journal

JF - ASAIO Journal

SN - 0162-1432

IS - 6

ER -